ArticleThe Journal of international medical research2025
Association of serum lipid levels, triglyceride-glucose index, systemic immune-inflammation index, and platelet-to-lymphocyte ratio with colorectal cancer: A retrospective study from China.
Article in The Journal of international medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Study on the diagnostic value of lipid and systemic inflammatory markers in colorectal adenomatous polyps and the construction of a diagnostic model.BMC gastroenterology · 2026Article
- [The association between serum triglycerides and colorectal cancer incidence in community-dwelling middle-aged and older adults in Korea: a secondary analysis of a community-based prospective cohort].Journal of Korean biological nursing science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveThis retrospective case-control study aimed to explore the correlations of blood lipid levels, triglyceride-glucose index, systemic immune-inflammation index, and platelet-to-lymphocyte ratio with colorectal cancer and evaluate their potential value in early risk prediction.MethodsA total of 120 patients admitted to Anqing First People's Hospital between July 2022 and March 2025 were categorized into a control group (n = 60, normal colonoscopy) and an observation group (n = 60, colorectal cancer). Clinical and laboratory data, including sex, age, body mass index, lipid profile, blood glucose, and blood counts, were collected. Triglyceride-glucose index, systemic immune-inflammation index, and platelet-to-lymphocyte ratio were calculated accordingly.ResultsThe observation group had significantly higher rates of drinking history, body mass index, triglyceride, total cholesterol, low-density lipoprotein cholesterol, triglyceride-glucose index, systemic immune-inflammation index, and platelet-to-lymphocyte ratio (P < 0.05). Triglyceride was strongly positively correlated with triglyceride-glucose index (r = 0.921) and negatively correlated with platelet-to-lymphocyte ratio (r = -0.189). Logistic regression identified drinking history (odds ratio = 5.015) and triglyceride-glucose index (odds ratio = 5.937) as independent risk factors. The receiver operating curve of triglyceride-glucose index showed an area under the curve of 0.713, with 78.3% specificity and 65% sensitivity.ConclusionTriglyceride-glucose index, along with blood lipid levels, systemic immune-inflammation index, and platelet-to-lymphocyte ratio, is closely associated with colorectal cancer. Triglyceride-glucose index may be a promising biomarker for early screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.